QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

Help viewing high resolution images Return to article

Fig. 10. CAP350 antagonizes transcriptional transactivation by endogenous PPAR in vivo. (A) H4IIEC3 cells were transfected with the reporter plasmid pTK-PPRE(x3)-Luc in the presence or absence of the PPAR ligand Wy-14,643 (100 µM) and increasing amounts of the CAP350 expression vector pMT-hCAP350 (0-0.5 µg/plate), as indicated. Luciferase activity was measured 48 hours posttransfection. The values are the average (±s.d.) fold-induction relative to untreated cells (taken as 1) from three independent transfections carried out in triplicate and normalized for protein and the levels of expression of ß-galactosidase from the plasmid pCMVLacZ used to control for transfection efficiency.(B) An amino-terminal fragment of CAP350 antagonizes PPAR-mediated transcriptional activity in an LXXLL-dependent manner. H4IIEC3 cells were transfected with the reporter plasmid pTK-PPRE(x3)-Luc in the presence or absence of the PPAR ligand, Wy-14,643 (100 µM) and expression vectors for EYFP-CAP350, EYFP-CAP350_1-890, EYFP-CAP350_1-890(LSHAA) or EYFP alone (designated by the (–) symbol), as indicated. Luciferase activity was measured as above.

Return to article